Focus On Health Care

Pharma Pipelines, by the Numbers

Europe’s pharma pipeline disclosure is more detailed than in the U.S., where drugs in phase I trials are not always disclosed. This means counting the total number of drugs in development is more accurate in Europe.

Gambrell is a contributing graphics editor for Bloomberg Businessweek.

Silicon Valley State of Mind

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus